StocksFundsScreenerSectorsWatchlists
LNTH

LNTH - Lantheus Holdings Inc Stock Price, Fair Value and News

62.37USD+0.89 (+1.45%)Market Closed

Market Summary

LNTH
USD62.37+0.89
Market Closed
1.45%

LNTH Alerts

  • 2 major insider sales recently.

LNTH Stock Price

View Fullscreen

LNTH RSI Chart

LNTH Valuation

Market Cap

4.3B

Price/Earnings (Trailing)

13.08

Price/Sales (Trailing)

3.3

EV/EBITDA

8.39

Price/Free Cashflow

14

LNTH Price/Sales (Trailing)

LNTH Profitability

EBT Margin

31.70%

Return on Equity

40.04%

Return on Assets

19.78%

Free Cashflow Yield

7.14%

LNTH Fundamentals

LNTH Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

34.52%

Rev. Growth (Qtr)

10.64%

LNTH Earnings

Earnings (TTM)

326.7M

Earnings Growth (Yr)

186.74%

Earnings Growth (Qtr)

-21.66%

Breaking Down LNTH Revenue

Last 7 days

1.4%

Last 30 days

6.7%

Last 90 days

17.5%

Trailing 12 Months

-31.1%

How does LNTH drawdown profile look like?

LNTH Financial Health

Current Ratio

5.8

Debt/Equity

0.69

Debt/Cashflow

0.54

LNTH Investor Care

Shares Dilution (1Y)

1.46%

Diluted EPS (TTM)

4.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.0B1.1B1.2B1.3B
2022541.6M664.2M801.5M935.1M
2021341.2M376.3M389.8M425.2M
2020351.5M331.8M334.6M339.4M
2019347.3M347.4M344.3M347.3M
2018332.6M329.4M338.3M343.4M
2017306.7M317.6M324.5M331.4M
2016295.1M299.8M298.7M301.9M
2015303.1M300.8M299.2M293.5M
20140289.6M295.6M301.6M
2013000283.7M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Lantheus Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 15, 2024
sabens andrea
sold
-20,882
61.24
-341
chief accounting officer
Mar 15, 2024
marshall robert j. jr.
sold
-1,200,000
60.00
-20,000
cfo and treasurer
Mar 13, 2024
sabens andrea
sold
-20,623
60.48
-341
chief accounting officer
Mar 07, 2024
blanchfield paul
sold
-1,116,710
61.96
-18,023
president
Mar 07, 2024
blanchfield paul
gifted
-
-
-500
president
Mar 06, 2024
leno sam r
sold
-129,857
63.4999
-2,045
-
Mar 06, 2024
leno sam r
acquired
33,333
16.3
2,045
-
Mar 05, 2024
leno sam r
sold
-132,148
64.6199
-2,045
-
Mar 05, 2024
sabens andrea
sold (taxes)
-415,690
65.36
-6,360
chief accounting officer
Mar 05, 2024
blanchfield paul
sold (taxes)
-1,354,780
65.36
-20,728
president

1–10 of 50

Which funds bought or sold LNTH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 17, 2024
Stanley-Laman Group, Ltd.
added
28.03
1,050,550
4,733,600
0.66%
Apr 17, 2024
NEW MEXICO EDUCATIONAL RETIREMENT BOARD
sold off
-100
-874,000
-
-%
Apr 16, 2024
Stratos Wealth Advisors, LLC
new
-
1,282,640
1,282,640
0.08%
Apr 16, 2024
CAMPBELL NEWMAN ASSET MANAGEMENT INC
added
2.42
58,227
2,124,810
0.17%
Apr 15, 2024
NorthCrest Asset Manangement, LLC
unchanged
-
1,063
275,723
0.01%
Apr 15, 2024
EXCHANGE TRADED CONCEPTS, LLC
reduced
-28.71
-17,684
44,502
-%
Apr 15, 2024
Andina Capital Management, LLC
new
-
370,515
370,515
0.29%
Apr 15, 2024
Sunbelt Securities, Inc.
unchanged
-
4.00
1,058
-%
Apr 12, 2024
ARMSTRONG ADVISORY GROUP, INC
unchanged
-
-
6,200
-%
Apr 12, 2024
HARBOR INVESTMENT ADVISORY, LLC
new
-
1,867
1,867
-%

1–10 of 45

Are Funds Buying or Selling LNTH?

Are funds buying LNTH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own LNTH
No. of Funds

Unveiling Lantheus Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
janus henderson group plc
5.8%
3,962,606
SC 13G
Feb 13, 2024
vanguard group inc
10.18%
6,973,141
SC 13G/A
Jan 23, 2024
blackrock inc.
12.6%
8,600,964
SC 13G/A
Feb 10, 2023
blackrock inc.
11.9%
8,213,720
SC 13G/A
Feb 09, 2023
vanguard group inc
10.53%
7,247,124
SC 13G/A
Jan 26, 2023
blackrock inc.
11.9%
8,203,470
SC 13G/A
Jan 20, 2023
blackrock inc.
11.9%
8,203,470
SC 13G/A
Jul 11, 2022
vanguard group inc
10.84%
7,438,724
SC 13G/A
Feb 15, 2022
armistice capital, llc
0%
0
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
3.1%
2,165,371
SC 13G/A

Recent SEC filings of Lantheus Holdings Inc

View All Filings
Date Filed Form Type Document
Apr 17, 2024
4
Insider Trading
Apr 15, 2024
144
Notice of Insider Sale Intent
Apr 04, 2024
3
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 15, 2024
144
Notice of Insider Sale Intent
Mar 15, 2024
4
Insider Trading
Mar 15, 2024
ARS
ARS
Mar 15, 2024
DEF 14A
DEF 14A
Mar 15, 2024
DEFA14A
DEFA14A
Mar 13, 2024
144
Notice of Insider Sale Intent

Peers (Alternatives to Lantheus Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
351.1B
85.2B
-6.70% -10.33%
9.99
4.12
6.46% 95.94%
317.1B
60.1B
2.45% 9.70%
868.73
5.27
1.40% -97.49%
143.3B
46.5B
-8.14% -36.93%
-103.22
3.08
42.59% -114.62%
140.8B
28.2B
-3.32% 6.70%
20.96
4.99
7.09% 2.52%
82.4B
27.1B
-9.93% -21.39%
14.54
3.04
-0.60% 23.36%
14.3B
15.8B
-4.27% 50.53%
-24.85
0.9
6.17% 76.47%
MID-CAP
4.1B
4.7B
-0.96% -17.31%
-319.58
0.87
4.58% 90.97%
4.0B
1.7B
-14.12% -18.81%
11.17
2.39
49.61% 324.78%
3.1B
8.8B
-9.85% 14.21%
-5.31
0.36
7.79% -163.11%
1.9B
644.4M
-13.30% -10.60%
13.51
2.88
29.14% 50.51%
SMALL-CAP
1.3B
743.2M
-9.90% -28.22%
-3.8
1.8
24.65% 80.36%
21.7M
1.3M
-17.90% -49.05%
-2.11
16.65
-98.14% -109.18%
17.6M
-
-9.57% 32.48%
-0.96
0.22
2882.68% -138.52%
2.5M
19.6M
-30.19% -94.45%
-0.18
0.13
80.00% 43.08%
422.3K
117.6M
-96.45% -95.94%
0
0
-0.79% -283.60%

Lantheus Holdings Inc News

Latest updates
MarketBeat9 hours ago
Yahoo Finance15 Apr 202401:50 pm
Zacks Investment Research05 Apr 202403:18 pm
Yahoo Finance08 Mar 202408:00 am

Lantheus Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue10.6%35432032230126323922420913010210193.0094.0089.0066.0091.0089.0086.0086.0087.0086.00
Gross Profit15.0%23020020377.0016714713812958.0043.0046.0041.0039.0036.0026.0038.0045.0042.0045.0044.0044.00
  S&GA Expenses-5.7%35.0037.0036.0033.0027.0025.0027.0020.0019.0017.0018.0014.0013.0012.006.0010.0010.0010.0011.0010.0010.00
  R&D Expenses16.4%17.0014.0016.0031.0027213.0015.0012.0011.0011.0012.0010.0013.0012.004.004.004.005.006.005.005.00
EBITDA Margin167.4%0.38*0.14*0.08*0.02*0.09*0.27*0.17*0.04*-0.06*0.03*0.05*----------
Interest Expenses-0.3%5.005.005.005.003.002.001.002.002.002.002.003.003.003.002.002.002.002.005.005.005.00
Income Taxes25.1%35.0028.0030.00-8.30-57.0622.0019.0015.00-0.79-6.42-1.885.001.00-1.080.002.00-8.051.002.003.004.00
Earnings Before Taxes-13.5%138160124-11.10-17683.0062.0058.00-41.01-19.84-28.5414.00-2.84-7.46-6.706.002.005.008.0013.0013.00
EBT Margin296.8%0.32*0.08*0.02*-0.04*0.03*0.20*0.09*-0.06*-0.18*-0.09*-0.07*----------
Net Income-21.7%10313294.00-2.81-11961.0043.0043.00-40.22-13.41-26.669.00-3.41-6.39-7.013.0010.005.006.0010.0013.00
Net Income Margin191.8%0.25*0.09*0.03*-0.02*0.03*0.13*0.05*-0.07*-0.17*-0.09*-0.07*----------
Free Cashflow-3.8%112117-32.2710910594.0073.0010.0014.004.0026.00----------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets8.5%1,6511,5221,3381,3491,3211,0961,014933864848858843870880880404406402390444440
  Current Assets14.5%1,086948752773678502404325236202186168184185181180173154140195195
    Cash Equivalents16.2%71461441447141625717110599.0091.0092.0069.0083.0088.0090.0096.0093.0078.0057.00112113
  Inventory13.4%64.0056.0052.0042.0035.0035.0034.0034.0035.0034.0032.0030.0036.0038.0035.0031.0029.0031.0032.0032.0033.00
  Net PPE----------------109116114113112108
  Goodwill0%61.0061.0061.0061.0061.0061.0061.0061.0061.0061.0061.0061.0059.0058.0045.0016.0016.0016.0016.0016.0016.00
Liabilities1.5%835823785904874458446417399348350315356366364286291301298361369
  Current Liabilities6.1%18717715427624823621917890.0077.0074.0065.0081.0082.0076.0062.0066.0060.0053.0043.0053.00
  Long Term Debt0.2%562561559559558152156159163167169171198205210181184186189263264
    LT Debt, Current17.1%1.001.000.000.000.0015.0014.0013.0012.0010.0010.0010.0021.0018.0017.0010.0010.0010.0010.003.003.00
    LT Debt, Non Current-----558---163--171198205210181184186189263264
Shareholder's Equity16.8%81669955344644763856751646449950852851451451611811510192.0083.0071.00
  Retained Earnings343.2%13430.00-101-195-193-73.97-135-178-221-181-167-140-149-146-140-133-136-146-151-158-168
  Additional Paid-In Capital1.8%758744730717716708700692685681676670666662658254252249245242240
Shares Outstanding0.1%70.0070.0070.0070.0069.0069.0068.0068.0067.0068.0068.00----------
Float---5,673---4,487---1,850---947---1,091--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-3.8%112,287116,739-32,266108,500105,35293,56872,59710,26413,8894,34025,8699,8185698,575-2,1569,40822,42126,44221,05310,46817,306
  Share Based Compensation1.4%14,17213,97612,6929,6678,1248,1037,4125,6234,1623,8674,5883,3173,6233,9923,3853,0752,9913,4233,3582,7202,299
Cashflow From Investing-114.5%-12,06983,218-20,697-44,513-264,724-6,090-4,343-1,390-4,544-2,420-2,65613,303-3,785-3,7365,307-2,698-4,741-3,336-3,434-10,550-7,366
Cashflow From Financing-516.7%-450108-4,051-8,669317,840-1,959-2,011-2,179-2,100-1,726-715-34,791-4,373-7,270-6,486-3,732-2,823-1,900-72,927-1,231-934

LNTH Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenues$ 1,296,429$ 935,061$ 425,208
Cost of goods sold586,886353,358237,513
Gross profit709,543581,703187,695
Operating expenses   
Sales and marketing141,736100,24368,422
General and administrative125,458133,584150,395
Research and development77,707311,68144,966
Total operating expenses344,901545,508263,783
Gain on sales of assets0015,263
Operating income (loss)364,64236,195(60,825)
Interest expense20,0197,1857,752
Loss (gain) on extinguishment of debt0588(889)
Other (income) loss, net(66,320)1,7037,350
Income (loss) before income taxes410,94326,719(75,038)
Income tax expense (benefit)84,282(1,348)(3,759)
Net income (loss)$ 326,661$ 28,067$ (71,279)
Net income (loss) per common share:   
Basic (in dollars per share)$ 4.79$ 0.41$ (1.06)
Diluted (in dollars per share)$ 4.65$ 0.40$ (1.06)
Weighted-average common shares outstanding:   
Basic (in shares)68,26668,48767,486
Diluted (in shares)70,23970,67167,486

LNTH Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 713,656$ 415,652
Accounts receivable, net284,292213,397
Inventory64,02935,475
Other current assets16,68313,092
Assets held for sale7,1590
Total current assets1,085,819677,616
Property, plant and equipment, net146,697122,166
Intangibles, net151,985315,285
Goodwill61,18961,189
Deferred tax assets, net150,198110,647
Other long-term assets55,26134,355
Total assets1,651,1491,321,258
Current liabilities  
Current portion of long-term debt and other borrowings823354
Accounts payable41,18920,563
Short-term contingent liability099,700
Accrued expenses and other liabilities145,338127,084
Total current liabilities187,350247,701
Asset retirement obligations22,91622,543
Total long-term debt, net, and other borrowings561,670557,712
Other long-term liabilities63,32146,155
Total liabilities835,257874,111
Commitments and contingencies (see Note 19)
Stockholders’ equity  
Preferred stock ($0.01 par value, 25,000 shares authorized; no shares issued and outstanding)00
Common stock ($0.01 par value, 250,000 shares authorized; 69,863 and 68,851 shares issued as of December 31, 2023 and 2022, respectively)699689
Additional paid-in capital757,727715,875
Treasury Stock at cost - 1,339 shares as of December 31, 2023 and 2022(75,000)(75,000)
Retained earnings (accumulated deficit)133,503(193,158)
Accumulated other comprehensive loss(1,037)(1,259)
Total stockholders’ equity815,892447,147
Total liabilities and stockholders’ equity$ 1,651,149$ 1,321,258
LNTH
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; and Cardiolite, an injectable Tc-99m-labeled imaging agent. The company also offers AZEDRA, a radiotherapeutic therapy; Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; PNT2002 for pre-chemotherapy patients; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; and PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer. The company serves hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacies, clinics, distirbutors, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; and FUJIFILM. The company was founded in 1956 and is based in Bedford, Massachusetts.
 CEO
 WEBSITElantheus.com
 INDUSTRYPharmaceuticals
 EMPLOYEES698

Lantheus Holdings Inc Frequently Asked Questions


What is the ticker symbol for Lantheus Holdings Inc? What does LNTH stand for in stocks?

LNTH is the stock ticker symbol of Lantheus Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lantheus Holdings Inc (LNTH)?

As of Thu Apr 18 2024, market cap of Lantheus Holdings Inc is 4.27 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LNTH stock?

You can check LNTH's fair value in chart for subscribers.

What is the fair value of LNTH stock?

You can check LNTH's fair value in chart for subscribers. The fair value of Lantheus Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Lantheus Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LNTH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Lantheus Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether LNTH is over valued or under valued. Whether Lantheus Holdings Inc is cheap or expensive depends on the assumptions which impact Lantheus Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LNTH.

What is Lantheus Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, LNTH's PE ratio (Price to Earnings) is 13.08 and Price to Sales (PS) ratio is 3.3. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LNTH PE ratio will change depending on the future growth rate expectations of investors.